Progyny Q4 revenue up 10.6% to $298.4 million; net income falls to $10.5 million
Progyny reported fourth-quarter and full-year 2024 results on February 27, 2025. Revenue grew in both periods, but net income declined, mainly because of a higher income tax provision tied to equity compensation. For 2025, the company guided revenue to $1.175 billion to $1.225 billion and net income to $45.0 million to $53.9 million, a range below 2024's $54.3 million, and said a large client did not renew its services agreement for 2025.
Key points
- Q4 2024 revenue was $298.4 million, up 10.6%; net income was $10.5 million, or $0.12 per diluted share, versus $13.5 million, or $0.13, a year earlier.
- Full-year 2024 revenue was $1.167 billion, up 7.2%; net income was $54.3 million, or $0.57 per diluted share, versus $62.0 million, or $0.62.
- 2025 guidance: revenue of $1.175 billion to $1.225 billion and net income of $45.0 million to $53.9 million.
- Q1 2025 guidance: revenue of $300.0 million to $318.0 million and net income of $15.0 million to $17.8 million.
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.